Late diabetes complications and non-dipping phenomenon in patients with Type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 71, Issue 1, 2006, Pages 14-20

  Stella, Peter ^a   Tabak, Adam Gy ^b   Zgibor, Janice C ^c   Orchard, Trevor J ^c  

^a Szent Imre Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Late diabetes complications; Non dipping phenomenon; Type 1 diabetes

Indexed keywords

ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXCRETION; FEMALE; HEART RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON DIPPING PHENOMENON; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; URINE;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PROTEINURIA;

EID: 29244463861     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.05.001     Document Type: Article

References (35)

1. DCCT Research Group. The Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329 (14) (1993) 977-986.
2. P. Reichard, B. Berglund, A.B.I. Cars, B.Y. Nilsson, and U. Rosenqvist Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM) J Int. Med. 230 1991 101 103
3. T.J. Orchard, J.S. Dorman, and R.E. Maser Factors associated with avoidance of severe complications after 25 years of IDDM. Pittsburgh epidemiology of diabetes complications study I Diab. Care 13 7 1990 741 747
4. B. Karamanos, M. Porta, and M. Songini Different risk factors of microangiopathy in patients with Type 1 diabetes mellitus of short versus long duration. The EURODIAB IDDM complications study Diabetologia 43 3 2000 348 355
5. D.M. Nathan The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann. Int. Med. 124 1 1996 86 89
6. B.A. Coonrod, D. Ellis, and D.J. Becker Predictors of microalbuminuria in individuals with IDDM Diab. Care 16 10 1993 1376 1383
7. A.S. Krolewski, D.G. Fogarty, and J.H. Warram Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diab. Res. Clin. Pract. 39 Suppl 1998 S1 S14
8. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruickshanks The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes Ophthalmology 105 10 1998 1801 1815
9. K.Y. Forrest, R.E. Maser, G. Pambianco, D.J. Becker, and T.J. Orchard Hypertension as a risk factor for diabetic neuropathy Diabetes 46 1997 665 670
10. G. Mancia, S. Omboni, and G. Parati The importance of blood pressure variability in hypertension Blood Press. Monit. 5 Suppl. 1 2000 S9 S15
11. T.B. Torbjornsdotter, G.A. Jaremko, and U.B. Berg Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with Type 1 diabetes Diabetologia 44 2001 865 873
12. H.P. Hansen, P. Hovind, B.R. Jensen, and H.-H. Parving Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy Kidney Int. 61 1 2002 163 168
13. M. Winnicki, C. Canali, P. Mormino, and P. Palatini Ambulatory blood pressure reproducibility and application of the method in a healthy Finnish cohort Scand. J. Clin. Lab. Invest. 56 1997 471 480
14. T.J. Orchard, J.S. Dorman, and R.E. Maser Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complications study II Diabetes 39 9 1990 1116 1124
15. D. Ellis, B.A. Coonrod, J.S. Dorman, S.F. Kelsey, E.D. Avner, and T.J. Orchard Choice of urine predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus Am. J. Kidney Dis. 13 1989 321 328
16. Early Treatment of Diabetic Retinopathy Study Coordinating Center. Manual of Operations. Baltimore: University of Maryland School of Medicine, 1980 (Chapters 5 and 18).
17. The DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes 37 (1988) 476-481.
18. R.E. Maser, V.K. Nielsen, and E.B. Bass Measuring diabetic neuropathy: assessment and comparison of clinical examination and quantitative sensory testing Diab. Care 12 1989 270 275
19. Arezzo J.C. (Physitemp Inst.), Quantitative sensory testing of vibration threshhold bitratron. II. Rationale and Methods, 1993.
20. N.O. Borhani, E.H. Kass, H.G. Langford, G.H. Payne, R.D. Remington, and J. Stamler The hypertension detection and follow-up program Prev. Med. 5 1976 207 215
21. G.R. Warnick, and J.J. Albers Heparin-MN(2+) quantitation of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples Clin. Chem. 24 1978 900 904
22. National Institutes of Health Department of Health Education and Welfare (US Government Printing Office). Lipid Research Clinics Program. Report no.: NIH publication no. 75-628, 1975.
23. C.C. Allain, L.S. Poon, Chan CSG, W. Richmond, and P.C. Fu Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 475
24. G. Bucolo, and H. David Quantitative determination of serum triglycerides by the use of enzymes Clin. Chem. 19 1973 476 482
25. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipiprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
26. P. Stella, D. Ellis, R.E. Maser, and T.J. Orchard Cardiac autonomic neuropathy (expiration and inspiration ratio) in Type 1 diabetes. Incidence and predictors J. Diab. Compl. 14 2000 1 6
27. W.B. Kannel, D. McGee, and T. Gordon A general cardiovascular risk profile: the Framingham study Am. J. Card. 38 1976 46 51
28. L. Hansson, A. Zanchetti, and S.G. Carruthers Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial HOT study group Lancet 351 1998 1755 1762
29. K.W. Hansen, P.L. Poulsen, E. Ebbehoj, and C.E. Mogensen What is hypertension in diabetes? Ambulatory blood pressure in 137 normotensive and normoalbuminuric Type 1 diabetic patients Diab. Med. 18 2001 370 373
30. G. Mancia, and G. Parati Ambulatory blood pressure monitoring and organ damage Hypertension 36 2000 894 900
31. W.B. White Ambulatory blood pressure monitoroing: dippers compared with non-dippers Blood Press. Monit. 5 Suppl. 1 2000 17 23
32. A.R. Lafferty, G.A. Werther, and C.V. Clarke Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with Type 1 diabetes Diab. Care 23 2000 533 538
33. V. Spallone, S. Gambardella, M.R. Maiello, A. Barini, S. Frontoni, and G. Menzinger Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients Diab. Care 17 1994 578 584
34. P.L. Poulsen, E. Ebbehoj, K.W. Hansen, and C.E. Mogensen 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients Diabetologia 40 1997 718 725
35. J.A. Meinhold, E. Maslowska-Wessel, R. Bender, and P.T. Sawicki Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy Diab. Med. 18 2001 607 613